Department of Food Engineering, Dankook University, Cheonan, 330-714, Korea.
Arch Pharm Res. 2012 Mar;35(4):683-9. doi: 10.1007/s12272-012-0412-4. Epub 2012 May 3.
To develop a novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose, it was prepared using spray-drying techniques with cycloamylose at a weight ratio of 1:1. The effect of cycloamylose on aqueous solubility of ibuprofen was investigated. The physicochemical properties of solid dispersions were investigated using scanning electron microscopy (SEM), differential scanning calorimetry (DSC), and X-ray diffraction. The dissolution and bioavailability in rats were evaluated compared with ibuprofen powder. This ibuprofen-loaded solid dispersion improved about 14-fold drug solubility. Ibuprofen was present in an unchanged crystalline state, and cycloamylose played the simple role of a solubilizing agent in this solid dispersion. Moreover, the dispersion gave 2-fold higher AUC (area under the drug concentration-time curve) value compared with a ibuprofen powder, indicating that it improved the oral bioavailability of ibuprofen in rats. Thus, the solid dispersion may be useful to deliver ibuprofen with enhanced bioavailability without crystalline change.
为了开发一种新型的布洛芬固体分散体,以提高生物利用度,使用环麦芽七糖,通过喷雾干燥技术,以 1:1 的重量比制备。考察了环麦芽七糖对布洛芬水溶性的影响。采用扫描电子显微镜(SEM)、差示扫描量热法(DSC)和 X 射线衍射法研究了固体分散体的物理化学性质。与布洛芬粉末相比,评价了其在大鼠体内的溶解和生物利用度。这种布洛芬负载的固体分散体提高了约 14 倍的药物溶解度。布洛芬以未改变的晶态存在,而环麦芽七糖在该固体分散体中仅起到增溶作用。此外,与布洛芬粉末相比,该分散体的 AUC(药物浓度-时间曲线下面积)值提高了 2 倍,表明其提高了布洛芬在大鼠体内的口服生物利用度。因此,该固体分散体可能有助于提供具有增强生物利用度的布洛芬,而不会发生晶体变化。